4//SEC Filing
BELLICUM PHARMACEUTICALS, INC 4
Accession 0001358403-16-000272
CIK 0001358403operating
Filed
Sep 22, 8:00 PM ET
Accepted
Sep 23, 6:55 PM ET
Size
13.7 KB
Accession
0001358403-16-000272
Insider Transaction Report
Form 4
Moseley Ken
Vice President
Transactions
- Sale
Common Stock
2016-09-21$20.04/sh−100$2,004→ 344 total - Sale
Common Stock
2016-09-23$20.10/sh−11,700$235,198→ 344 total - Exercise/Conversion
Stock Option (right to buy)
2016-09-21−100→ 40,817 totalExercise: $7.47Exp: 2024-11-10→ Common Stock (100 underlying) - Exercise/Conversion
Common Stock
2016-09-23$7.47/sh+11,700$87,399→ 12,044 total - Exercise/Conversion
Stock Option (right to buy)
2016-09-23−11,700→ 29,117 totalExercise: $7.47Exp: 2024-11-10→ Common Stock (11,700 underlying) - Exercise/Conversion
Common Stock
2016-09-21$7.47/sh+100$747→ 444 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 24, 2015 by the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]25% of the shares subject to the stock option vest and become exercisable on November 11, 2015, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter.
Documents
Issuer
BELLICUM PHARMACEUTICALS, INC
CIK 0001358403
Entity typeoperating
Related Parties
1- filerCIK 0001358403
Filing Metadata
- Form type
- 4
- Filed
- Sep 22, 8:00 PM ET
- Accepted
- Sep 23, 6:55 PM ET
- Size
- 13.7 KB